Abstract:Background: The relationship between antibody levels (more generally, a scalar measure of immune protection) at the time of exposure to infection (so-called exposure-proximal correlates of protection) and the risk of infection given exposure is of central interest in evaluating the evolution of immune protection conferred by prior infection and/or vaccination. A version of the test-negative study design (TND), adapted from vaccine effectiveness studies, has been used to assess this relationship. However, the conditions under which such a study identifies the relationship between immune measurements and protection have not been defined. Objective: To evaluate the conditions for TNDs to estimate the relationship between antibody levels or a similar scalar measurement of immunity (hereafter exposure-proximal correlates of protection, COP) and the relative incidence rate of infection given exposure. Method: Individual-based transmission models, linking infection risk linearly and nonlinearly with COP value and accounting for waning immunity post-vaccination and -infection, were used. Simulations were performed of a TND with sampling on predetermined dates. Data from either one or multiple simulation days were analyzed using logistic regression and generalized additive models. Result: A correctly specified logistic regression model provided an unbiased estimate of the effectiveness of specific COP levels (analogous to vaccine effectiveness). Aggregating data across different simulation dates with incidence-density sampling also provided reliable estimates of protection. When, as is generally the case, the functional form relating COP level to protection is unknown, generalized additive models offer a more flexible alternative to traditional logistic regression approaches. Conclusion: A TND can validly estimate the relative effect of an immune COP at the time of exposure on the incidence rate of infection via logistic regression if the functional form of the effect is known and appropriately modeled or unknown a semiparametric approach. Future research should further examine the dynamics of immunity waning and boosting for more reliable inference.

Improved Methods for Vaccine Effectiveness Studies

Test negative design for vaccine effectiveness estimation in the context of the COVID-19 pandemic: A systematic methodology review

Double Negative Control Inference in Test-Negative Design Studies of Vaccine Effectiveness

Potential Biases in Test-Negative Design Studies of COVID-19 Vaccine Effectiveness Arising from the Inclusion of Asymptomatic Individuals

Severity-dependent test-seeking behaviors and test-negative designs: impact on estimated vaccine effectiveness and utility of analytic and design choices

TNDDR: Efficient and doubly robust estimation of COVID-19 vaccine effectiveness under the test-negative design

A Double Machine Learning Approach for the Evaluation of COVID-19 Vaccine Effectiveness under the Test-Negative Design: Analysis of Quebec Administrative Data

Impact of unequal testing on vaccine effectiveness estimates across two study designs: a simulation study

Identifying and alleviating bias due to differential depletion of susceptible people in post-marketing evaluations of COVID-19 vaccines

Designs for Vaccine Studies

Investigating confounding in network-based test-negative design influenza vaccine effectiveness studies-Experience from the DRIVE project

Test-negative Design:Basic Principles,Methods of Implementation,Types of Derivatives,Advantages, Limitations,and Applications

Estimating Waning of Vaccine Effectiveness: a Simulation Study

A novel approach for estimating vaccine efficacy for infections with multiple outcomes: application to a COVID-19 vaccine trial

Use of the test-negative design to estimate the protective effect of a scalar immune measure: A simulation analysis

Adjustment for Disease Severity in the Test-Negative Study Design

Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls

Sensitivity Analysis for the Test-Negative Design

Efficient nonparametric inference on the effects of stochastic interventions under two-phase sampling, with applications to vaccine efficacy trials

Improving precision of vaccine efficacy evaluation using immune correlate data in time-to-event models